Search Results
Results found for "Patricia Drake"
Posts (64)
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
November 2021 "November 11, 2021 7:00am EST Patricia Drake appointed new Chief Commercial Officer CHESTERBROOK medicines for patients with central nervous system (CNS) disorders, today announced the addition of Patricia Drake to its senior leadership team as Chief Commercial Officer."
- PLC-IP3-ORAI pathway participates in the activation of the MRGPRB2 receptor in mouse peritoneal...
September 2022 PLC-IP3-ORAI pathway participates in the activation of the MRGPRB2 receptor in mouse peritoneal
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
March 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B biotech company with a unique portfolio of CB1 inverse agonists, announced today the dosing of the first participant
Other Pages (3)
- Booklet for participants | Dr. GPCR Ecosystem
Your complete guide to AGPCR24. Inside, you’ll find the schedule, speaker bios, venue map, travel tips, and essential information to make the most of your workshop experience. OFFICIAL BOOKLET Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF You can also download the booklet by scanning this QR code
- Dr. Patrick Sexton | Dr. GPCR Ecosystem
Patrick Sexton About Dr. Patrick Sexton Patrick Sexton is a Professor of Pharmacology, National Health and Medical Research Council Patrick Sexton on the web CCeMMP Monash University Dr.
- Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against diet-induced obesity
Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Removing the GPCR-mediated brake
